References

1. Metchnikoff E. The Prolongation of Life. New York: G. Putnam's Sons, 1908.

2. Tissier H. Traitement des infections intestinales par la methode de la flore bacterienne de l'intestin. Crit Rev Soc Biol 1906; 60:359-361.

3. Kim HS, Gilliland SE. Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans. J Dairy Sci 1983; 66:959-966.

4. van Niel CW, Freudtner C, Garrison MM. Christakis, D.A. Lactobacillus therapy for acute infectious diarrhoea in children: a meta-analysis. Pediatrics 2002; 109:678-684.

5. Ohashi Y, Nakai S, Tsukamoto T, et al. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int 2002; 68:273-280.

6. Orrhage K, Sjostedt S, Nord CE. Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil. J Antimicrob Chemother 2000; 46:603-611.

7. Gardiner GE, Heinemann C, Bruce AW, Beuerman D, Reid G. Persistence of Lactobacillus fermentrum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diag Lab Immunol 2002; 9:92-96.

8. Marteau P, Cuillerier E, Meance S, et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 2002; 16:587-593.

9. Lilly DM, Stillwell RH. Therapeutic properties of substances produced by lactic acid bacteria. Science 1965; 147:747-748.

10. Food and Agriculture Organization of United Nations and World Health Organization 2001. Regulatory and clinical aspects of dairy probiotics. Food and Agriculture

Organization of United Nations and World Health Organization Expert Consultant Report. Food and Agriculture Organization of United Nations and World Health Organization Working Group Report (Online).

Food and Agriculture Organization of United Nations and World Health Organization 2002. Guidelines for the evaluation of probiotics in food. Food and Agriculture Organization of United Nations and World Health Organization Working Group Report (Online).

Dunne C, O'Mahony L, Murphy L. In vitro selection criteria for probiotic bacteria of human origin:correlation with in vivo findings. Am J Clin Nutr 2001; 73:386S-392S. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276:G941-G950.

Mattila-Sandholm T, Salminen S. Up-to-date on probiotics in Europe. Gastroenterol Intern 1998; 1:8-12.

Ventura M, Zink R. Rapid identification, differentiation, and proposed new taxonomic classification of Bifidobacterium lactis. Appl Environ Microbiol 2002; 68:6429-6434. Gardiner GE, Heinemann C, Baroja ML, et al. Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications. Int Dairy J 2002; 12:191-196.

Ouwehand AC, Vesterlund S. Health aspects of probiotics. IDrugs 2003; 6:573-580. Collins JK, Thornton G, O'Sullivan G. Selection of probiotic strains for human applications. Int Dairy J 1998; 8:487-490.

Gardiner GE, Ross RP, Kelly PM, Stanton C, Collins JK, Fitzgerald G. Microbiology of therapeutic milks. In: Robinson RK, ed. Dairy Microbiology Handbook: The Microbiology of Milk and Milk Products. New York: Wiley Interscience Publishers, 2002:431-468. Havenaar R, Huis in't Veld JHJ. In: Wood BJB, ed. Lactic Acid Bacteria in Health and Disease. London: Elsevier Applied Science Publishers, 1992:151-170. Kohwi Y, Hashimoto Y, Tamura Z. Antitumor and immunological adjuvant effect of Bifidobacterium adolescentis M 101-104. Biosci Biotech Biochem 1982; 57:2127-2132. Lee YK, Salminen S. Probiotics in gastrointestinal disorders. Trends Food Sci Technol 1995; 6:241-245.

Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344:1046-1049.

Breslaw ES, Kleyn DH. Factors affecting growth of Bifidobacteria. Food Sci 1973; 38:1016-1021.

Mantere-Alhonen S. Fermented milks and human health. Meijeritieteellinen Aikakauskirja 1983; 41:217-237.

Pattersson L, Graf W, Sewelin U. Symposium of the swedish nutrition foundation. XV. In: Hallgren Bo, ed. Nutrition and the Intestinal Flora. Stockholm, Sweden: Almquist & Wiksell International, 1983.

Lindwall S, Fonden R. Fermented Milks and Health, FIL/IDF Doc. 1984; 179:21-33 Yakult Honsha Co. Ltd. 1971. The summary of Reports Yakult. Yakult Honsha Co. Ltd. 11-19, Higshi Shinbashi, Minato-ku, Tokyo, Japan and Intestinal flora of microorganisms and health. Prospectus.

Huis in't Veld JHJ, Shortt C. Gut flora and health- past, present and future. In: Leeds RA, Rowland IR, eds. International Congress and Symposium Series No. 219. London: Royal Society of Medicine Press, 1996:27-39.

Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003; 16:658-672.

Fooks LJ, Gibson GR. Probiotics as modulators of the gut flora. Br J Nutr 2002; 88:S39-S49.

Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 1987; 70:1-12.

33. Alm L, Leijenmark CE, Persson AK, Midtvedt T. The regulatory and protective role of the normal microflora. In: WennerGren International Symposium Series. 1988;52: 293-297.

34. Mountzouris KC, McCartney AL, Gibson GR. Intestinal microflora of human and infants and current trends for its nutritional modulation. Br J Nutr 2002; 87:405-420.

35. Salminen SJ, Gueimonde M, Isolauri E. Probiotics that modify disease risk. J Nutr 2005; 135:1294-1298.

36. Kado-oka Y, Fujiwara S, Hirota T. Effects of bifidobacteria cells on mitogenic response of splenocytes and several functions of phagocytes. Milchwissenschaft 1991; 46:626-630.

37. Sekine K, Ohta J, Onishi M, et al. Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis. Biol Pharm Bull 1995; 18:148-152.

38. Yasui H, Nagaoka N, Mike A, Hayakawa K, Ohwaki M. Detection of Bifidobacterium strains that induce large quantities of IgA. Microb Ecol Health Dis 1992; 5:155-162.

39. Kishi A, Uno K, Matsubara Y, Okuda C, Kishida T. Effect of the oral administration of Lactobacillus brevis subsp. coagulans on interferon-a producing capacity in humans. J Am Coll Nutr 1996; 15:408-412.

40. Sekine K, Kawashima T, Hashimoto Y. Comparison of the TNF-a levels induced by human-derived Bifidobacterium longum and rat-derived Bifidobacterium animalis in mouse peritoneal cells. Bifidobact Microflora 1994; 13:79-89.

41. Hosono A, Lee J, Ametani A, et al. Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M 101-4. Biosci Biotech Biochem 1997; 61:312-316.

42. Tone-Shimokawa Y, Toida T, Kawashima T. Isolation and structural analysis of polysaccharide containing galactofuranose from the cell walls of Bifidobacterium infantis. J Bacteriol 1996; 178:317-320.

43. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus GG) promotes recovery from acute diarrhoea in children. Paediatrics 1991; 88:90-97.

44. Isolauri E, Kaila M, Mykkanen H, Ling WH, Salminen S. Oral bacteriotherapy for gastroenteritis. Digest Dis Sci 1994; 39:2595-2600.

45. Kalia M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhoea by human Lactobacillus strain. Paed Res 1992; 32:141-144.

46. Majaama H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Paed Gastroenterol Nutr 1995; 20:333-339.

47. Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. Lactobacillus GG promotes recovery form acute non-bloody diarrhoea in Pakistan. Pediatr Infect Dis J 1995; 14:107-111.

48. Salminen S, Ouwehand AG, Benno Y, Lee YK. Probiotics: how should they be defined? Trends Food Sci Technol 1999; 10:107-110.

49. Shornikova AV, Casas IA, Isolauri E, Mykkanan H, Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhoea in young children. J Pediatr Gastroenterol Nutr 1997; 24:399-404.

49a. Shu Q, Hai L, Rutherfurd KJ, Fenwick SG, Gopal PK, Gill HS. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium in mice. Microbiol Immunol 2000; 44:213-222.

50. Shu Q, Gill HS. Imune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR10™) against Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol 2002; 34:59-64.

51. Hotta M, Sato SIN. Clinical effects of Bifidobacterium preparation on pediatric intractable diarrhoea. Keio J Med 1987; 36:298-314.

52. Colombel JF, Corot A, Neut C, Romond C. Yogurt with Bifidobacterium longum reduces erythromycin-induced gastro-intestinal effects. Lancet 1987; 2:43-44.

Sittonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobacillus GG yogurt in prevention of antibiotic associated diarrhoea. Ann Med 1990; 22:57-59.

Borgia M, Sepe N, Brancato V, Borgia RA. A controlled clinical study on Streptococcus faecium preparation for the prevention of side reactions during long-term antibiotic therapy. Curr Therapeutic Res 1982; 31:265-271.

Surawicz CM, Elmer LW, Speelman P, McFarland LV, Chinn J, vanBelle G. Prevention of antibiotic-associated diarrhoea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96:981-988.

Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health. BMJ 1999; 318:999-1003.

Elmer GW, Surawicz C, McFarland L. Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections. J. Am. Med. Asso. 1996; 275:870-876.

Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile Colitis with Lactobacillus GG. Lancet 1987; 26:1519-1522.

Bartlett JG, Chang TW, Gurwith M. Antibiotic-associated pseudomembraneous colitis due to toxin-producing clostridia. N Engl J Med 1982; 57:141-145.

Bennet RG, Laughon B, Lindsay J. 1990. Lactobacillus GG treatment of Clostridium difficile infection in nursing home patients. Abstract, 3rd International Conference on Nosocomial Infections. Atlanta.

Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 1995; 21:224-226. Black FT, Andersen PL, Orskov F, Gaarslev K, Laulund S. Prophylactic efficacy of lactobacilli on traveller's diarrhoea. Travellers Med 1989; 8:1750-1753. Oksanen PJ, Salminen S, Saxelin M, Hamalmein P, Arja IV, Leena MI, Seppo N, Oksanen T, Posti I, Salminen E, Siitonen S, Struckey H, Topilla A, Vapaatalo H. Prevention of traveller's diarrhoea by Lactobacillus GG. Ann Med 1990; 22:53-56. Hilton E, Kolakowski P, Smith M, Singer C. Efficacy of Lactobacillus GG as a diarrhoea preventive measure. J Travellers Med 1996; 4:3-7.

Nomoto K, Nagaoka M, Yokokura T, Mutai M. Augmentation of resistance of mice to bacterial infection by a polysaccharide peptidoglycan complex (PSPG) extracted from Lactobacillus casei. Biotherapy 1989; 1:169-171.

Hitchins AD, Wells P, McDonough FE, Wong NP. Amelioration of the adverse effect of gastrointestinal challenge with Salmonella enteriditis on weaning rats by a yogurt diet. Am J Clin Nutr 1986; 41:91-100.

Bovee-Oudenhoven I, Termont D, Dekker R, Van der Meer R. Calcium in milk and Fermentation by yogurt bacteria increase the resistance of rats to Salmonella infection. Gut 1996; 38:59-65.

Brassart D, Neeser JR, Michetti P, Sevin A. The selection of dairy bacterial strains with probiotic properties based on their adhesion to human intestinal epithelial cells. Les Bacteries Lactiques/Lact ic Acid Bacteria. AdriaNormandie: Presses Unversitaires de Caen, 1995 pp. 201-202.

Sepp E, Tamm E, Torm S, Lutsar I, Mikelsaar M, Salminem S. Impact of a Lactobacillus probiotics on the faecal microflora in children with shigellosis. Microecol Ther 1995; 23:74-80.

Majaama H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20:333-338. Isolauri E, Kiijavainen PV, Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 2002; 50:iii54-iii59.

Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35:483-489.

Lundgren O, Svensson L. Pathogenesis of rotavirus diarrhea. Microbes Infect 2001; 3:1145-1156.

71. Ward LA, Rosen BI, Yuan L, Saito LJ. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J Gen Virol 1996; 77:1431-1441.

72. Reid G, Charbonneau D, Gonzalez S, Gardiner G, Erb J, Bruce AW. Ability of Lactobacillus GR-l and RC-14 to stimulate host defences and reduce gut translocation and infectivity of Salmonella typhlmurium. Nutraceut Food 2002; 7:168-173.

73. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002; 168:171-178.

74. Yolken RH, Ojeh C, Khatri IA, Sajjan U, Forstner JF. Intestinal mucins inhibit rotavirus replication in an oligosaccharide-dependent manner. J Infect Dis 1994; 169:1002-1006.

75. Xu J, Verstraete W. Evaluation of nitric oxide production by lactobacilli. Appl Microbiol Biotechnol 2001; 56:504-507.

76. Cadieux P, Burton J, Gardiner G, et al. Lactobacillus strains and vaginal ecology. JAMA 2002; 287:1940-1941.

77. Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126:520-528.

78. Mohamadzadeh M, Olson S, Kalina WV, et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA 2005; 102:2880-2885.

79. Gorbach SL, Nahas L, Lerner PI. Studies on intestinal microflora I: Effects of diet, age and periodic sampling on numbers of faecal microorganisms in man. Gastroenterology 1967; 53:845-855.

80. Cummings JH, Macfarlane GT. A review: the control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 1991; 70:443-459.

81. Blaut M, Collins MD, Welling GW, Dore J, van Loo J, de Vos W. Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br J Nutr May 2002; 87:S203-S211.

82. Alander M, De Smet I, Nollet L, Verstraete W, Mattila-Sandholm T. The effect of probiotic strains on the microbiota of the simulator of the human intestinal microbial ecosystem (SHIME). Int J Food Microbiol 1999; 46:71-79.

83. Benno Y, Hosono M, Hashimoto H, Kojima T, Yamazaki K, Iino H. Effects of Lactobacillus GG yoghurt on human intestinal microecology in Japanese subjects. Nutr Today 1996; 31:9S-12S.

84. Aso Y, Akazan H. Prophylactic effect of Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol Int 1992; 49:125-129.

84a. Marteau P, Flourie B, Pochart P. Effect of chronic ingestion of a fermented dairy product containing lactobacillus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 1990; 52:685-688.

85. Khedkar CD, Patil MR, Gyananath G, et al. Studies on implantationability of a probiotic culture of Lactobacillus acidophilus in gastrointestinal tract of tribal children. In Proceedings of International Seminar and Workshop on Fermented Foods, health status and social well-being, held at Anand(India) 2003:62-63.

86. Khedkar CD, Gyananath G, Patil MR, Bajad DN, Khojare AS, Sarode AR. 2006. Studies on effect of feeding probiotic Lactobacillus supplemented with Propionibacterium culture on gastrointestinal microflora of tribal children. Lait (In press).

87. Gopla PK, Prasad J, Gill HS. Effects of consumption of Bifidobacterium lactis DR10 and galactooligosaccharides on the microecology of the gastrointestinal tract in human subjects. Nutr Res 2001; 23:1313-1318.

88. Altermann E, Russell WM, Azcarate-Peril MA, et al. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proc Natl Acad Sci USA 2005; 102:3906-3912.

89. Bongaerts GPA, Severijnen RSVM. The beneficial, antimicrobial effect of probiotics. Med Hypotheses 2001; 56:174-177.

Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002; 22:283-307. van Nuenen MHMC, Meyer PD, Venema K. The effect of various inulins and Clostridium difficile on the metabolic activity of the human colonic microbiota in vitro. Microb Ecol Health Dis 2003; 15:137-144.

Tsukahara T, Iwasaki Y, Nakayama K, Ushida K. Microscopic structure of the large intestinal mucosa in piglets during an antibiotic associated diarrhea. J Vet Med Sci 2003; 65:301-306.

Oozeer R, Mater DD, Goupil-Feuillerat N, Corthier G. Initiation of protein synthesis by a labeled derivative of the Lactobacillus casei DN-114 001 strain during transit from the stomach to the cecum in mice harboring human microbiota. Appl Environ Microbiol 2004; 70:6992-6997.

Hove H, Nordgaard-andersen I, Brobech Mortensen P. Effect of lactic acid bacteria on the intestinal production of lactate and short-chain fatty acids, and the absorption of lactose. Am J Clin Nutr 1994; 59:74-79.

Girard-Pipau F, Pompei A, Schneider S, et al. Intestinal microflora, short chain and cellular fatty acids, influence of a probiotic Saccharomyces boulardii. Microb Ecol Health Dis 2002; 14:220-227.

St-Onge M-P, Farnworth ER, Savard T, Chabot D, Mafu A, Jones PJH. Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relatiev to milk in hyperlipidemic men: a randomized controlled trial. BMC Complement. Altern Med 2002; 2:1-789.

Goossens D, Jonkers D, Russel M, Stobberingh E, van den Bogaard A, Stockbrugger R. The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Aliment Pharmacol Ther 2003; 18:495-505.

Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 1998; 52:899-907.

Tannock GW, Munro K, Harmsen HJM, Welling GW, Smart J, Gopal PK. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 2000; 66:2578-2588.

Guerin-Danan C, Chabanet C, Pedone C, et al. Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microflora in healthy infants. Am J Clin Nutr 1998; 67:111-117.

Fujiwara S, Seto Y, Kimura A, Hashiba H. Establishment of orally administered Lactobacillus gasseri SBT 2055 SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism. J Appl Microbiol 2001; 90:343-352. Pedrosa MC, Golner BB, Goldin BR, Barakat S, Dallal GE, Russell RM. Survival of yoghurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypochlorhydric elderly subjects. Am J Clin Nutr 1995; 61:353-359.

Ling WH, Hanninen O, Mykkanen H, Heikura M, Salminen S, von Wright A. Colonization and fecal enzyme activities after oral Lactobacillus GG administration in elderly nursing home residents. Ann Nutr Metab 1992; 36:162-166.

Hosoda M, He F, Kojima T, Hashimoto H, Iino H. Effects of fermented- milk with

Lactobacillus rhamnosus GG strain administration on defecation, putrefactive metabolites and fecal microflora of healthy volunteers. J Nutr Food 1998; 1:1-9.

Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of

Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992;

37:121-128.

Ouwehand AC, Lagstrom H, Suomalainen T, Salminen S. The effect of probiotics on constipation, faecal azoreductase activity and faecal mucins. Ann Nutr Metab 2002; 46:159-162.

105. Tomoda T, Nakano Y, Kageyama T. Effect of yogurt and yogurt supplemented with Bifidobacterium and/or lactulose in healthy persons: a comparative study. Bifidobact. Microflora 1991; 10:123-130.

106. Goldin BR, Gorbach SL. The relationship between diet and rat faecal bacterial enzymes implicated in colon cancer. J Natl Cancer Inst 1976; 57:371-375.

107. Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human faecal microbiotia in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001; 152:735-741.

108. Hughes R, Rowland IR. Metabolic activities of the gut microflora in relation to cancer. Microb Ecol Health Dis 2000; 11:179-185.

Weight Loss Enigma

Weight Loss Enigma

Finally Revealed The Revolutionary & Miraculous Weight Loss Secrets! Discover How to Command Those Unwanted Pounds To Take A Hike, So That You Can Get Into Shape & Lose Weight Easily Just Like You Dream Of In Just A Matter Of Weeks! You're About to Discover The Insider's Fat Burning Diet Tips to Easily Shed Off Those Extra Pounds And Obtain a Lovable Shape In No Time Flat!

Get My Free Ebook


Post a comment